Formyl peptide receptor 2: Difference between revisions
CSV import |
CSV import |
||
| Line 31: | Line 31: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 13:08, 17 March 2025
Formyl peptide receptor 2 (FPR2), also known as ALX or FPRL1, is a protein that in humans is encoded by the FPR2 gene. This protein is a member of the G protein-coupled receptor family, and plays a crucial role in the immune system and inflammation response.
Structure[edit]
The FPR2 protein is a cell surface receptor that is predominantly expressed in immune cells such as neutrophils, monocytes, and macrophages. It is a seven-transmembrane domain receptor, which is a characteristic feature of G protein-coupled receptors.
Function[edit]
FPR2 is involved in the regulation of several key functions of the immune system. It is activated by a variety of ligands, including lipoxin A4 and serum amyloid A. Upon activation, FPR2 triggers a series of intracellular signaling pathways that lead to various immune responses, such as chemotaxis, phagocytosis, and the production of reactive oxygen species.
Clinical significance[edit]
Alterations in the function or expression of FPR2 have been implicated in a variety of diseases, including chronic obstructive pulmonary disease, asthma, rheumatoid arthritis, and Alzheimer's disease. Therefore, FPR2 is considered a potential therapeutic target for these conditions.
Research[edit]
Research on FPR2 is ongoing, with studies focusing on understanding its role in the immune system and its potential as a therapeutic target. Some studies are investigating the use of FPR2 agonists and antagonists in the treatment of inflammatory diseases.
See also[edit]
References[edit]
<references />
| Lymphocytic adaptive immune system and complement | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Inflammation | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
